E-LIB Suche - Ergebnisse für: Stupp, R

1

155P Outcomes in patients with resectable stage III NSCLC w..:

Almeida, S. Cardoso ; Schaer, S. ; Hayoz, S....
ESMO Open. 9 (2024) - p. 102910 , 2024

Link: https://doi.org/10.1016/..

2

OS09.4.A RANO 2.0: UPDATE TO THE RESPONSE ASSESSMENT IN NEU..:

Wen, P ; Van Den Bent, M ; Youssef, G...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii21-ii21 , 2023

Link: https://doi.org/10.1093/..

3

JS07.4.A REGIONAL B-CELL MEDIATED IMMUNOSUPPRESSION IDENTIF..:

Kada Benotmane, J ; Arrieta, V A ; Zhao, J...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii11-ii11 , 2023

Link: https://doi.org/10.1093/..

4

Association of pre-radiotherapy tumour burden and overall s..:

Alafandi, A. ; van Garderen, K.A. ; Klein, S....
European Journal of Cancer. 188 (2023) - p. 122-130 , 2023

Link: https://doi.org/10.1016/..

5

Neoadjuvant treatment does not influence PD-L1 expression i..:

König, D. ; Savic Prince, S. ; Hayoz, S....
ESMO Open. 8 (2023) 4 - p. 101595 , 2023

Link: https://doi.org/10.1016/..

6

Long-term outcomes of operable stage III NSCLC in the pre-i..:

König, D. ; Schär, S. ; Vuong, D....
ESMO Open. 7 (2022) 2 - p. 100455 , 2022

Link: https://doi.org/10.1016/..

7

OS07.3.A Phase 1/2 clinical trial of blood-brain barrier op..:

Idbaih, A ; Sonabend, A ; Stupp, R...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii16-ii16 , 2022

Link: https://doi.org/10.1093/..

8

P09.03.A Associations of levetiracetam use with the safety ..:

Seystahl, K ; Oppong, F B ; Le Rhun, E...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii47-ii47 , 2022

Link: https://doi.org/10.1093/..

9

Corrigendum to 'Long-term outcomes of operable stage III NS..:

König, D. ; Schär, S. ; Vuong, D....
ESMO Open. 7 (2022) 3 - p. 100494 , 2022

Link: https://doi.org/10.1016/..

10

OS05.3.A Temporal muscle thickness as surrogate parameter o..:

Furtner, J ; Weller, M ; Weber, M...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii7-ii7 , 2021

Link: https://doi.org/10.1093/..

11

Characterizing Seizure-Induced Changes in the Glioma Microe..:

Sita, T. ; Hurley, L. ; Dussold, C....
International Journal of Radiation Oncology*Biology*Physics. 111 (2021) 3 - p. e599-e600 , 2021

Link: https://doi.org/10.1016/..

12

PL03.4.A Factors associated with health-related quality of ..:

Coomans, M ; Dirven, L ; Aaronson, N...
Neuro-Oncology. 23 (2021) Supplement_2 - p. ii2-ii3 , 2021

Link: https://doi.org/10.1093/..

13

OS7.2 Measuring change in health-related quality of life: t..:

Coomans, M ; Taphoorn, M J B ; Aaronson, N...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii14-iii14 , 2019

Link: https://doi.org/10.1093/..

14

OS7.4 Calculating the net clinical benefit in brain tumor c..:

Coomans, M ; Dirven, L ; Bottomley, A...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii14-iii15 , 2019

Link: https://doi.org/10.1093/..

15

P01.032Associations of anticoagulant use with outcome in ne..:

Le Rhun, E ; Genbrugge, E ; Stupp, R...
Neuro-Oncology. 20 (2018) suppl_3 - p. iii235-iii235 , 2018

Link: https://doi.org/10.1093/..